COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network Study.

Autor: Anderson AR; PRISMA Health Comprehensive Sickle Cell Disease Program, Division of Pediatric Hematology-Oncology, University of South Carolina School of Medicine, Greenville, SC., Strouse JJ; Division of Hematology, Department of Medicine, Duke University School of Medicine, Durham, NC., Manwani D; Children's Hospital at Montefiore, Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY., Brandow AM; Department of Pediatrics, Section of Hematology/Oncology/Bone Marrow Transplantation, Medical College of Wisconsin and Children's Research Institute of Children's Wisconsin, Milwaukee, WI., Vichinsky E; Benioff Children's Hospital Oakland, Department of Pediatrics, UCSF, Oakland, CA., Campbell A; Department of Pediatrics, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC., Leavey PJ; Simmons Comprehensive Cancer Center, Children's Medical Center, Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX., Nero A; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX., Ibrahim IF; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX., Field JJ; Department of Medicine, Medical College of Wisconsin, Versiti Blood Research Institute, Milwaukee, WI., Baer A; Department of Medicine, University of Pennsylvania, Philadelphia, PA., Soto-Calderon H; Department of Medicine, University of Pennsylvania, Philadelphia, PA., Vincent L; Department of Medicine, University of Pennsylvania, Philadelphia, PA., Zhao Y; Department of Microbiology, University of Pennsylvania, Philadelphia, PA., Santos JJS; Department of Microbiology, University of Pennsylvania, Philadelphia, PA., Hensley SE; Department of Microbiology, University of Pennsylvania, Philadelphia, PA., Mortier N; ASH Research Collaborative, Washington, DC., Lanzkron S; Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD., Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Abrams CS; Department of Medicine, University of Pennsylvania, Philadelphia, PA.

Publikováno v: Blood advances [Blood Adv] 2024 Sep 10; Vol. 8 (17), pp. 4549-4553.

Cell-specific regulation of gene expression using splicing-dependent frameshifting.

Autor: Ling JP; Departments of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. jling@jhu.edu.; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. jling@jhu.edu.; Kavli Neuroscience Discovery Institute, Johns Hopkins University, Baltimore, MD, 21218, USA. jling@jhu.edu., Bygrave AM; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Santiago CP; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Carmen-Orozco RP; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Trinh VT; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Yu M; Department of Ophthalmic Research, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, 44195, USA.; Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, 44195, USA., Li Y; Departments of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Liu Y; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Bowden KD; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA., Duncan LH; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Han J; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Taneja K; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Dongmo R; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Babola TA; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA., Parker P; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Jiang L; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Leavey PJ; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Smith JJ; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Zanvyl Krieger Mind/Brain Institute, Johns Hopkins University, Baltimore, MD, 21218, USA., Vistein R; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Zanvyl Krieger Mind/Brain Institute, Johns Hopkins University, Baltimore, MD, 21218, USA., Gimmen MY; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Dubner B; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Helmenstine E; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Teodorescu P; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Karantanos T; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Ghiaur G; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Kanold PO; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Kavli Neuroscience Discovery Institute, Johns Hopkins University, Baltimore, MD, 21218, USA.; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA., Bergles D; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Kavli Neuroscience Discovery Institute, Johns Hopkins University, Baltimore, MD, 21218, USA., Langmead B; Kavli Neuroscience Discovery Institute, Johns Hopkins University, Baltimore, MD, 21218, USA.; Department of Computer Science, Johns Hopkins University, Baltimore, MD, 21218, USA., Sun S; Departments of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Nielsen KJ; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Kavli Neuroscience Discovery Institute, Johns Hopkins University, Baltimore, MD, 21218, USA.; Zanvyl Krieger Mind/Brain Institute, Johns Hopkins University, Baltimore, MD, 21218, USA., Peachey N; Department of Ophthalmic Research, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, 44195, USA.; Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, 44195, USA.; Research Service, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, 44106, USA., Singh MS; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Dalton WB; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Rajaii F; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Huganir RL; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Kavli Neuroscience Discovery Institute, Johns Hopkins University, Baltimore, MD, 21218, USA., Blackshaw S; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. sblack@jhmi.edu.; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. sblack@jhmi.edu.; Zanvyl Krieger Mind/Brain Institute, Johns Hopkins University, Baltimore, MD, 21218, USA. sblack@jhmi.edu.; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. sblack@jhmi.edu.; Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. sblack@jhmi.edu.

Publikováno v: Nature communications [Nat Commun] 2022 Oct 01; Vol. 13 (1), pp. 5773. Date of Electronic Publication: 2022 Oct 01.

An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.

Autor: Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Whittle SB; Texas Children's Cancer and Hematology Centers, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Surdez D; Bone Sarcoma Research Laboratory, Balgrist University Hospital, University of Zurich, Zurich, Switzerland., Bailey KM; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., de Álava E; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC/Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, Seville, Spain., Yustein JT; Texas Children's Cancer and Hematology Center and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, USA., Shlien A; Department of Laboratory Medicine and Pathobiology/Department of Paediatric Laboratory Medicine/Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada., Hayashi M; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO, USA., Bishop AJR; Greehey Children's Cancer Research Institute and Department of Cell Systems and Anatomy, University of Texas Health at San Antonio, San Antonio, TX, USA., Crompton BD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Shukla N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Leavey PJ; Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX, USA., Lessnick SL; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, and the Division of Pediatric Heme/Onc/BMT, The Ohio State University College of Medicine, Columbus, OH, USA., Kovar H; St. Anna Children´s Cancer Research Institute (CCRI) and Department Pediatrics Medical University of Vienna, Vienna, Austria., Delattre O; INSERM U830, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Center, Institut Curie Research Center, Paris, France., Grünewald TGP; Hopp-Children's Cancer Center (KiTZ), Heidelberg/Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK)/Institut of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Antonescu CR; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Roberts RD; Center for Childhood Cancer and Blood Disease, Nationwide Children's Hospital and The Ohio State University, Columbus, OH, USA., Toretsky JA; Departments of Oncology and Pediatrics, Georgetown University, Washington, DC, USA., Tirode F; Univ Lyon, Universite Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, Centre Leon Berard, F-69008, Lyon, France., Gorlick R; Division of Pediatrics, MD Anderson Cancer Center, Houston, TX, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Reed D; Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL, USA., Lawlor ER; Seattle Children's Research Institute, University of Washington Medical School, Seattle, WA, USA., Grohar PJ; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA. GROHARP@EMAIL.CHOP.EDU.

Publikováno v: NPJ precision oncology [NPJ Precis Oncol] 2022 Sep 17; Vol. 6 (1), pp. 65. Date of Electronic Publication: 2022 Sep 17.

Correlation of histopathology and multi-modal magnetic resonance imaging in childhood osteosarcoma: Predicting tumor response to chemotherapy.

Autor: Teo KY; Department of Computer Science, University of Texas at Dallas, Richardson, Texas, United States of America., Daescu O; Department of Computer Science, University of Texas at Dallas, Richardson, Texas, United States of America., Cederberg K; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Sengupta A; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Leavey PJ; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.

Publikováno v: PloS one [PLoS One] 2022 Feb 14; Vol. 17 (2), pp. e0259564. Date of Electronic Publication: 2022 Feb 14 (Print Publication: 2022).

Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report.

Autor: Leavey PJ; UT Southwestern Medical Center Dallas and Children's Health, Children's Medical Center Dallas, Dallas, TX., Laack NN; Mayo Clinic, Rochester, MN., Krailo MD; University of Southern California, Los Angeles, CA., Buxton A; Children's Oncology, Operations Office, Monrovia, CA., Randall RL; UC Davis, Sacramento, CA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA., Reed DR; Moffitt Cancer Center Adolescent and Young Adult Program, Tampa, FL., Grier HE; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA., Hawkins DS; Seattle Children's Hospital, Seattle, WA., Pawel B; Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA., Nadel H; Lucile Packard Children's Hospital Stanford University, Palo Alto, CA., Womer RB; Children's Hospital of Philadelphia, Philadelphia, PA., Letson GD; Moffitt Cancer Center Adolescent and Young Adult Program, Tampa, FL., Bernstein M; IWK Health Center, Halifax, NS., Brown K; British Columbia Children's Hospital, Vancouver, BC, Canada., Maciej A; University of Minnesota Medical Center, Minneapolis, MN., Chuba P; St John Hospital and Medical Center, Grosse Pointe, MI., Ahmed AA; The Children's Mercy Hospital, Kansas City, MO., Indelicato DJ; University of Florida, Jacksonville, FL., Wang D; Rush University Medical Center, Chicago, IL., Marina N; Stanford University School of Medicine, Lucile Packard Children's Hospital, Stanford, CA., Gorlick R; MD Anderson Cancer Center, Houston, TX., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA., Mascarenhas L; Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Dec 20; Vol. 39 (36), pp. 4029-4038. Date of Electronic Publication: 2021 Oct 15.